Skye Bioscience SKYE
NASDAQ SKYE
$1.60 -0.01 (-0.62%)
As of: Oct 1, 2026 · 3:59 PM EDT

Skye Bioscience (SKYE) Return on Assets [ROA] (2013 - 2026)

Updated

Skye Bioscience's Return on Assets [ROA] was -331.64% in Q2 2026, down 259.18 percentage points from -72.46% a year earlier and down 91.41 percentage points from the prior quarter.

Analysis

Skye Bioscience (SKYE) Return on Assets [ROA] (2013 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Skye Bioscience came in at -110.66%, down 47.93 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +170.41 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -62.73% in FY2024 (+294.92 pp), -357.64% in FY2023 (-152.21 pp), -205.44% in FY2022 (-69.37 pp) and -136.06% in FY2021 (+145.00 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q3 2023.
  • Compared with a year earlier, Return on Assets [ROA] has declined for five straight quarters, with an average year-over-year change of +3.91 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2024 (a gain of 577.86 percentage points); the worst was Q2 2023 (a drop of 446.94 percentage points).
  • Per Business Quant data, SKYE's Return on Assets [ROA] in the three quarters before Q2 2026 was -240.23% (Q1 2026), -160.62% (Q4 2025) and -109.60% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Skye Bioscience 7.07 Mn 7.07 Mn - -331.64%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -331.64%
Mar 31, 2026 -240.23%
Dec 31, 2025 -160.62%
Sep 30, 2025 -109.60%
Jun 30, 2025 -72.46%
Mar 31, 2025 -47.47%
Dec 31, 2024 -34.44%
Sep 30, 2024 -25.17%
Jun 30, 2024 -46.45%
Mar 31, 2024 -70.23%
Dec 31, 2023 -273.34%
Sep 30, 2023 -483.36%
Jun 30, 2023 -624.31%
Mar 31, 2023 -315.46%
Dec 31, 2022 -325.24%
Sep 30, 2022 -308.89%
Jun 30, 2022 -177.37%
Mar 31, 2022 -110.22%
Dec 31, 2021 -79.12%
Sep 30, 2021 -87.47%
API Access

Skye Bioscience Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SKYE&period=max&api_key=YOUR_API_KEY